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Reduction of Dental Decay in Rampant Caries Individuals
Following Short-Term Kanamycin Treatment
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Dental Research Institute, School of Dentistry,
Ann Arbor, Michigan 48109, USA
A week of kanamycin gel treatment before and
after the placement of dental restorations, com-
pared to a placebo gel treatment, significantly
reduced the levels of cultivable bacteria, S
mutans and S sanguis, in the plaque samples
collccted immediately after the completion of
the gel treatments, and was associated with a
46% reduction in new carious surfaces in the
14- to 37-month period following the gel treat-
ment.
Dental decay caused by Streptococcus mtutans
can be prevented or significan>ly reduced in ani-
nal models by the prolonged administration of
antibiotics in food and/or water.1 This treat-
ment regimen is not applicable to human beings
because of the problems associated with long-
term antibiotic therapy` and the impracticality
of adding antibiotics to food and water for hu-
man consumption. Short-term applications of
vancomycin, given topically in a gel, will lower
the proportions of S mutans in human
plaque.3 When vancomycin was given daily
during the school year, the levels of S mutans
and number of carious surfaces decreased
slightly, but significantly, compared to a group
receiving no treatment.5-6 Short-term applica-
tion of kanamycin, given topically in Orabase,
significantly reduced plaque weight and gin-
givitis scores in institutionalized patients when
compared with the placebo treatment.7 Tbe
plaque in the kanamycin-treated patients had
significantly fever streptococci than did the
plaque in the placebo-treated group.8 In the
present investigation, the effect of short-term
application of kanamycin or placebo gels on the
plaque levels of S mutans and Streptococcus
sanguis and on subsequent caries experience was
assessed in children and teenagers diagnosed as
having both rampant caries and elevated plaque
levels of S mutans.
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Materials and Methods
PATIENTS.-Forty-five voung individuals,
i.e., from 4 to 17 years old, who presented in
the private practice of one of the investigators
(DB) with ten or more carious surfaces were
invited to participate in the study. These pa-
tiCtets invariably did not consume fluoridated
wvater and had a history of frequent sucrose in-
gestion. Approximately two to five new patients
entcred the study per month. Thirty-one pa-
tients completed both weeks of gel treatment;
29 of these returned for recall appointments
over the next 14- to 37-month period.
DIAGNOSIS OF CARIESO-A clinical examin-
ation -with ani explorer alnd full mouth x-ray
films were used to enumerate the number of de-
cay ed surfaces at the initial visit (Table 1). Any
questionable lesions were considered as carious.
However, after completion of restorative and gel
treatmcnt, only sites where cavitation occurred
were diagnosed as being carious. In some in-
stances, this amounted to watching the progres-
TABLE 1
OUTLINE OF PROTOCOL FOR COMBINED KAN-
AMYCIN AND RESTORATIVE TREATMENT IN
CHILDREN DIAGNOSED AS HAVING
RAMPANT CARIES
1. Select patients with ten or more carious
surfaces and assign to Kanamycin or
placebo gel (double blind).
2. Treat for one week with gels. Take bac-
teriological samples from approximal and
occlusal sites and from the saliva, imme-
diately prior and after gel treatment.
3. Place dental restorations. This takes from
four to seven weeks.
4. Retreat for one week with gels. Take
bacteriological samples from approximal
and occlusal sites and saliva immediately
prior and after gel treatment.
5. Re-examination for cavitation at three-
month intervals. Take bacteriological
samples as before.
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TABLE 2
EFFECT OF KANAMYCIN OR PLACEBO GEL TREATMENTS GIVEN FOR 1 WEEK
BEFORE AND AFTER PLACEMENT OF DENTAL RESTORATIONS ON LEVELS
OF S mutans IN PLAQUE AND SALIVA
First Gel Treatment Second Gel Treatment
Before After Before After
Treatment Gel Restorations Gel
Kanamycin Treatment
Plaque CFU X 104/sample
Approximal 374 305 330t 106
Fissure 205* 49*t 50 3t
Saliva CFU X 104/ml 84 51 14 4t
No. of subjects 26 26 21 18
Placebo Treatment
Plaque CFU X 104/sample
Approximal 478 627 121t 71
Fissure 124 229t 59 122t
Saliva CFU X 104/ml 150 159 15 87t
No. of subjects 19 19 15 13
* Significant difference within treatment group before and after gel treatment P
<0.05 student t test.
t Significant difference between treatment groups before and after gel treatment
P < 0.05 student t test.
sion of a lesion over one or more recall visits to
the sta,e where it was frankly carious.
TREATMENT.-All patients received the
restorative dentistry, consisting of amalgams and
stainless steel crowns, that was necessary to de-
bride their teeth of decayed tissue. This phase
of treatment took from four to seven weeks. In
addition to this usual mechanical treatment, the
patients were assigned, on a double blind basis,
to the kanamycin or placebo gel treatment. The
gel treatment was given for a one-week period
immediately prior to the start of the restorative
dentistry and for a second week immediately
following the completion of the restorative den-
tistry (Table 1). The patient and/or his or her
parent were shown how to apply the gel to
standardized plastic trays (Fluoratray, Kerr,
Romulus, Mi) and to insert the trays laden with
gel into the patient's mouth. They were instruc-
ted to insert these trays for approximately five
minutes in the morning after breakfast and for
five minutes in the evening just before retiring.
The patients wvere given a week's supply of gel
and trays and were reques'-ed to record any
noncompliance with these instructions. The ac-
tual usage of the gels was unsupervised. The
patients and their parents were fully informed
that they were receiving either a prescription
drug or placebo drug. Approximately 10 to 15
minutes of office time was spent in this instruc-
t>on and demonstration of the gel application.
The gels contained 1.4% hydroxyethyl cel-
lulose, 0.24% methyl paraben, 0.04% propyl
paraben, 0.2% sodium saccharin, coloring and
flavoring agents and water (Davies, Rose Hoyt
Pharmaceutical Co., Needham, Ma). The
placebo gel was used as such, whereas 5% kana-
mycin sulfate (Kantrex, Bristol Laboratories,
Syracuse, NY) was added to the kanamycin
gel. The kanamycin gel was prepared by stirring
the powdered drug into the gel and then further
dispersing with a sonifier. The gels were evalu-
ated for their minimal inhibitory concentration
against plaque bacteria periodically during the
study and exhibited no loss of potency. The
addition of kanamycin to the gel caused no ap-
parent change in the taste of the gel.
BACTERIOLOGY. The following bacterio-
logical specimens were obtained before and
after each gel treatment and at the various re-
call visits (Table 1). Unstimulated saliva was
collected bv expectoration into a wide mouth
bottle and 1 ml was placed into 9 ml of reduced
transport fluid (RTF).9,10 Fissure plaque was
obtained by forcibly scratching the fissure
depths of the most distal tooth in each quadrant
wiLh a sterile pointed wire held with a sterile he-
mostat.1" A separate wire was used to sample
each of the four teeth. All four wires were
placed into the same 10 mls of RTF, so that
this specimen represented a pooling of fissure
plaque from the four molar areas of the mouth.
Approximal plaque was collected from the most
distal interproximal site in each quadrant by
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TABLE 3
EFFECT OF DENTAL RESTORATIONS AND KANAMYCIN OR PLACEBO GEL
TREATMENTS ON TOTAL VIABLE COUNT AND S sanguis COUNT IN
APPROXIMAL AND OCCLUSAL PLAQUES
Treatment
First Gel Treatment Second Gel Treatment


















































* Differences between groups are significantly different by student t test, P < 0.05.
means of unwaxed dental floss.1' The four sep-
arate floss samples were placed into the same
10 mls of RTF, so that this specimen repre-
sented a pooling of approximal plaque from the
four molar areas.
All samples were brought to the laboratory
within one to four hours after collection. They
were dispersed for five to ten seconds by sonifi-
cation, serially diluted, and appropriate dilu-
tions plated in duplicate on MM1O sucrose agar
(plaque samples)12,13 and MSB agar (plaque
and salivary samples).14 The plates were incu-
bated for four to seven days at 37 C in an atmos-
phere of 85% N2, 10% H2, and 5% CO2. The
total colony forming units (CFU), S mutans
and S sanguis colonies on the MM10 sucrose
plates and the S mutans counts on the MSB
plates were enumerated. Representative S mu-
tans colonies were tested for mannitol fermen-
tation.
STATISTICS.-The S mutans counts on both
media and the S sanguis counts on the MM10
sucrose medium were normalized as a percent-
age of the total CFU on the MM1O sucrose
medium for each plaque sample. The S mutans
count in saliva was recorded per ml of saliva.
The absolute and/or percent normalized data
for the plaque and salivary samples for the 2
treatment gels were compared by computer
using the MIDAS statistical programs available
in the Michigan Terminal System. The data
were tested for significance by both the para-
metric t test and the nonparametric median and
Kruskal Wallis Test.15
Results
The S mutans counts on the MM10 sucrose
agar were consistently higher than those on
MSB agar. In 510 samples that were cultured
on both media, the MM10 sucrose counts were
noticeably higher in 46% of the comparisons,
i.e., the S mutans count on MM10 was at least
10 CFU higher than that on MSB agar; were
approximately equal in 37% of the compari-
sons, i.e., the coulnt of S mutans on MM10 su-
crose agar and MSB were within 10 CFU of
each other; and were noticeably lower in 17%
of the comparisons, i.e., .he S mutans count on
MSB was at least 10 CFU higher than that on
MM10 sucrose.
Forty-five patients received the first gel
treatment and 31 received the second gel treat-
ment. There were no complaints concerning
taste of the gels and use of trays. All patients
reported that they used the gels according to
instructions.
The first gel treatment was given while
open carious lesions were present in the mouth.
The kanamycin gel lowered the levels of S
J Dent Res March 197;
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mutans in the plaques and saliva relative to the
placebo gel (Table 2). This difference between
groups was significant for the fissure plaques.
Within the kanamycin group, the antibiotic gel
caused a significant fivefold decrease in the fis-
sure levels of S mutans, but only slight ede-
creases in the approximal and salivary levels of
S mutans (Table 2). Within the placebo group,
the gel treatment was associated with an appre-
ciable increase in plaque levels of S mutans.
Dental restorations were placed in the pa-
tient's teeth during the next four to seven weeks.
At their completion, the restorations were
polished and the bacteriological samples col-
lected. In both groups, the salivary levels of S
mutans had decreased to about 15 X 104 organ-
isms per ml of saliva (Table 2). The approxi-
mal levels of S mutans were not significantly
higher in the kanamycin group, whereas the
fissure levels were comparable in both groups.
The gels were given for a second one-week peri-
od. The kanamycin gel reduced the approximal
levels of S mutans threefold, the fissure levels
16-fold and the salivary levels fourfold relative
to the before-treatment values (Table 2). The
placebo gel was associated with increases in the
fissure ;nd salivary levels of S mutans and a
decrease in the approximal levels. The differ-
ences in fissure and salivary levels of S mutans
between the groups were significant. S mutans
could not be detected in four fissures and in
three approximal samples obtained from the
kanamycin group, and in one approximal
sample obtained from the placebo group.
Kanamycin treatment also decreased the
anaerobic viable count and the S sanguis count
relative to the placebo treatment (Table 3).
This nonspecific reduction of plaque bacteria
caused a shift in the proportions of S mutans
and S sangui. n the plaque flora. In the approx-
imal plaque samples, kanamycin treatmlent was
associated with a significant increase in the pro-
portions of S mutans relative to the placebo
treatment (Table 4). This was due mainly to
three patients wvho had S mutans accounting
from 20 to 56% of the CFU. In the fissure
plaques, neither the kanamycin nor the placebo
treatments seemed to affect the proportions of
S mutans. The percent of S mutans in the ap-
proximal samples after the second period of
kanamycin treatment was significantly de-
creased relative to samples obtained from the
placebo patients.
The wvide range in values obtained sug-
gested that the data could be better analyzed
by nonparametric tests of significance. The val-
ues obtained at each visit for the measured
variables wvere ranked from low to high and
TABLE 4
EFFECT OF DENTAIL RESTORATIONS AND KANAMYCIN OR PLACEBO GEL
TREATMENTS OF PROPORTIONS OF S mutans AND
















First Gel Treatment Second Gel Treatment
Before After Before After
Gel Restorations Gel
Kanamycin Treatment
7.1 ± 9.5t 19.5 + 21.1t 5.0 + 5.9 9.7 + 14.1t




17.0 + 23.4 7.2 ± 8.7
7.5 ± 12 6.1 ± 4.8
26 21
Placebo Treatment
6.0 ± 7.7 6.4 ± 6.6t 3.4 ± 4.3 1.1 ± 1.4t










* Values given are percent of CFU on MM10 sucrose agar. When S mutans could not
be detected on MM10 sucrose agar, the counts of S mutans on MSB agar were substituted.
t Differences between groups are significant P < 0.05 student t test.
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analyzed by the Kruskal Wallis Test. There
were no significant differences between the kan-
amycin and placebo groups in any category
under investigation prior to the first gel treat-
ment (Table 5). After the first gel treatment,
the total counts and S sanguis counts of the ap-
proximal and fissure plaques were significantly
lower in the kanamycin group. The fissure
levels of S mutans decreased significantly, but
there was no alteration in the approximal levels.
These changes resulted in a significant increase
in the proportions of S mutans and the mutans-
sanguis (MS) ratio in the approximal plaques.
After the placement of dental restorations, the
total count and S mutans counts in the approx-
imal plaques were significantly higher and the
S sanguis counts significantly lowAer in the kana-
mycin group. No significant differences were
observed at this time in the fissure plaques. After
the second gel treatment, all the median values
decreased. The kanamycin subjects had signi-
ficantly lowel counts in all samples except for
the S mutans counts in the approximal plaques.
When the percent normalized values were com-
pared, the percent S mutans and the MS ratio
increased significantly and the percent S san-
guis decreased significantly in the approximal
plaques. No changes in the proportions of S
mutans and S sanguis were observed in the fis-
sure plaques.
The results indicated that the kanamycin
treatment was effective in reducing the bacterial
count in fissure and approximal plaque samples.
However, the significantly higher proportions
of S mutans and the higher MS ratio in approx-
imal plaques of the kanamycin-treated subjects
were considered undesirable. The clinical find-
ings on the first few patients at the nine-month
recall visit indicated that the number of new
carious lesions was higher in the kanamycin-
treated patielts. A decision was made to stop
the entry of new patients into the study and to
continue to observe, at recall visits, the plaque
levels of S mutans and S sanguis as well as the
new caries experience of the patients already in
the study.
Twenty-nine patients returned for four or
more recall visits in the 14- to 37-month period
following the second gel treatment. There were
no discernible differences at the time of entry
into the study between the 16 kanamycin and
the 13 placebo patients as to age, and bacter-
iological status (Tables 6). The number of
sound surfaces at risk after the completion of
the operative dentistry was remarkably similar
for both groups (Table 6). The second kanamy-
cin treatment in this group of patients had sig-
nificantly reduced the plaque levels of S mu-
tans, S sanguis, and other cultivable bacteria
relative to the placebo treatment (Tables 7 and
8). However, at the two- to four-month recall
visit and at all subsequent recall visits during
the first year the initial diffeirences between
the groups disappeared (Tables 7 and 8).
TABLE 6
CHARACTERISTICS AT ENTRY INTO STUDY OF 29 SUBJECTS WHO REMAINED
IN STUDY FOR AT LEAST 14 MONTHS AFTER PLACEMENT OF
RESTORATIONS AND (GEL) TREATMENT
Treatment Kanamycin Placebo
No. of Subjects 16 13
Age in Years 8.9 ± 4.0* (4-17)t 9.4 ± 3.3 (6-16)
Total Count X 104 Bacteriological Profile
Fissure 1376 ± 1804* (14-5750)t 1757 ± 1757 (49-5010)
Approximal 6066 ± 5986 (250-15900) 9298 ± 8928 (670-28650)
S mutans X 104
Fissure 183 ± 313 (1.9-905) 152 ± 142 (0.5-385)
Approximal 295 ± 429 (5-1400) 547 ± 709 (10-2125)
Saliva/ml 98 ± 141 (1.2-385) 82 ± 108 (1.7-374)
S sanguis X 104
Fissure 35 ± 48 (0.5-200) 45 ± 63 (2-210)
Approximal 261 ± 245 (5-900) 626 ± 1423 (20-5275)
Sound Surfaces at Risk After Placement of Restorations
Fissure 2.5 ± 2.6 (0-9) 2.5 ± 2.5 (0-7)
Approximal 33.1 ± 10.6 (10-51) 34.6 ± 8.6 (21-48)
Smooth 36.4 ± 9.6 (19-54) 37.2 + 8.7 (24-48)
* Mean ± standard deviation.
t Numbers in parenthesis give range of values.
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TABLE 7
EFFECT OF KANAMYCIN OR PLACEBO GEL TREATMENT ON LEVELS OF
S mutans AND S sanguis IN FISSURE PLAQUES AT
RECALL VISITS
Months
After Treatment 0 2-4 5-7 8-10 11-13
Total count X 103
S mutans X 103
MM1o
MSB




Total count X 103
S mutans X 103
MM1o
MSB





739* 5200 7686 5129
35* 227* 332 643
18* 202* 184 937
21* 300 192 263
7.1 14.8 4.9 8.8
4.6 5.6 8.9 5.1
16 10 10 12
Placebo Treatment

























* Differences between groups at each time period are significant, P < .05, Student
t test.
There was an unexplained significant decrease
in fissure S mutans levels in the placebo group
at the two- to four-month recall visit (Table 7).
Otherwise no significant differences were ob-
served. The salivary levels of S mutans ranged
from 10.5 to 45.6 X 104 organisms/ml of saliva
at the various recall visits with no differences
observed between the treatment groups.
The caries experience of the subjects dif-
fered according to the gel treatment. Eight of
16 kanamycin subjects and 9 of 13 placebo sub-
jects developed carious lesions during the 14 to
37 months following gel treatment (Table 9).
The three patients who developed the highest
number of new carious lesions were in the place-
bo group. A total of 30 lesions was detected
in the kanamycin-treated patients and 45 in the
placebo patients. In both groups approximately
64% of the lesions occurred on the fissure sur-
faces, 25% on the approximal surfaces, and
11% on the smooth surfaces (Table 10). Fis-
sure caries were first observed in the placebo
group at the six-month recall visit, and in the
kanamycin group at the nine-month recall visit
(Table 10). At the nine-month recall visit, the
kanamvcin patients had seven times the num-
ber of new carious surfaces than the placebo
patients (Fig 1). Thereafter, the incidence of
caries increased in the placebo group, so that
after 15 to 16 months the total number of cari-
ous surfaces was higher in this group and con-
tinued so for the remainder of the observation
period. The placebo group averaged 3.46 cari-
ous surfaces per subject, whereas the kanamycin
group averaged 1.88 carious surfaces. This re-
presents about a 46% reduction of new carious
surfaces in the kanamycin group when com-
pared with the placebo gToup. This reduction
was distributed among the surfaces as follows:
47% on the fissure surfaces, 41% on the ap-
proximal surfaces, and 50% on the smooth suf-
faces (Table 10). About 48% of the fissure sur-
faces at risk became carious in the kanamycin
group, whereas 89% of the surfaces at risk be-
came carious in the placebo group.
Discussion and Conclusions
The experimental protocol was based upon
the specific plaque hypothesis2 that the presence
of S mutans in high numbers in a plaque makes
that plaque cariogenic. Individuals who had
such S mutans dominated plaques were consid-
ered as having a specific infection that required
intensive, but short-term antimicrobial treat-
ment. A week of kanamnycin gel treatment prior
to and after the placement of dental restora-
tions, compared to a placebo gel treatment, sig-
nificantly reduced the levels of cultivable bac-
teria, S mutans, and S sanguis in the plaque
samples collected immediately after the com-
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TABLE 8
EFFECT OF KANAMYCIN OR PLACEBO GEL TREATMENT ON LEVELS OF
S mutans AND S sanguis IN APPROXIMAL PLAQUES
AT RECALL VISITS
Months
After Treatment 0 2-4 5-7 8-10 11-13
Total count X 104
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groups at each time period are significant, P < .05, Student
ated with a 46% reduction in new carious sur- system, such as dietary changes, the plaque
faces in the 14- to 37-months period following levels of S mutans returned with time and ap-
the gel treatment. The initial bacteriological proached the placebo levels. This accounting
differences between groups did not persist as does not suffice 'co explain how the short periods
there was no apparent treatment effect in the of kanamycin therapy caused the appreciable
plaque or saliva samples collected at any re- reductions in new carious lesions observed, nor
call visit during the first year following treat- why 70% of the new carious surfaces in the
ment. This would seem to indicate that the kanamycin group occurred by the nine-month
changes brought by the kanamycin treatment recall visit (Fig 1). The clinical findings indi-
were inadequate to elimninate S mutans, and cate that kanamycin treatment accelerated the
given no osher perturbations in the eco- rate of caries development on some surfaces,
TABLE 9
FREQUENCY DISTRIBUTION OF NEW CARIOUS SURFACES SEEN AT RECALL
IN PATIENTS TREATED WITH EITHER KANAMYCIN OR PLACEBO GELS
Kanamycin Placebo
Cumulative Cumulative
No. of Carious No. of Sum of No. of Sum of
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TABLE 1 0
NEW CARIOUS SURFACES SEEN AT RECALL VISITS IN PATIENTS TREATED WITH
EITHER KANAMYCIN OR PLACEBO GELS
Kanamycin Placebo
Patient Months in Carious Surfacel Patient Months in Carious Surface$
Number Study F AP S Number Study F AP S
1 14* 0 0 0 1 18* 4(18) 4(18) 0
2 15* 0 0 0 2 20* 0 0 0
3 19* 0 0 0 3 24 3(6) 0 0
4 24 3(9)t 1(9) 0 4 24 0 4(12) 0
5 31 0 0 0 5 26 8(15) 0 0
6 31 5(9) 1(15) 0 6 27* 0 0 0
1(21)
7 31 5(15) 0 0 7 29 1(16) 0 0
8 31 0 0 0 8 30 0 0 2(12)
9 31 0 0 0 9 31 6(12) 0 1(12)
10 32 0 4(9) 3(9) 7(24)
11 32 0 0 0 10 36 0 1(15) 2(15)
12 32 2(9) 0 0 11 36 0 2(12) 0
13 34 2(9) 1(9) 0 12 36 0 0 0
14 36 1(30) 0 0 13 36 0 0 0
15 37 1(12) 0 0
16 37 0 0 0
Total Carious
Surfaces 19 8 3 29 11 5
Surfaces Per
Patient 1.19 0.5 0.19 2.23 0.85 0.38
Percent
Reduction 47 41 50
Per Surface
* Patient has dropped from study.
t Months after gel treatment when cavitation was diagnosed
t Number of fissure (F), approximal (AP), or smooth (S) surfaces which became carious with time.
while preventing the development of caries on
other surfaces. This paradoxical effect can be
explained by a caries model which acknowledges
the existence of a primary carious lesion that is
not capable of being diagnosed by the clinician,
and by the assumption that this primary lesion
represents a focal infection or proliferation of
S mutans or some other organism(s) which is
involved in caries formation. This primary le-
sion would include the zone of subsurface de-
mineralization that is klnown to precede cavita-
tion and other earlier stages of the decay proc-
ess. Plaques overlying buccal surface "wviite
spots" have recently been shown to have higher
levels of S mutans than plaques taken only mil-
limeters away from clinically normal enamel,
a fiinding which supports the focal proliferation
concept (van Houte and Duchin, personal com-
munication).
In this model, depicted in Fig 2, the tooth
surface has three situations relative to health or
disease: (1) the cariesfree surface, (2) the pri-
mary lesion, and (3) the secondary lesion of
obvious cavitation. Each of these surfaces will
respond differently to an effectively delivered
antimicrobial agent. On the cariesfree surfaces
the active agent will reduce the total number of
bacteria, possibly eliminating S mutans as is
shown in Fig 2 for kanamycin treatment. This
agrees with the general reduction in viable count
and S mutans seen following both periods of
kanamycin therapy (Tables 2 and 3).
In the primary lesion, an antimicrobial
agent may not penetrate to the deepest layers
of plaque or enter into the demineralized zones,
so that a nidus of bacteria consisting of those
organisms at the advancing front of the lesion
will survive. In the reformation of plaque, these
bacteria could grow out of the lesion and com-
prise a higher proportion of the plaque flora
(Fig 2). In the present investigation, an enrich-
ment for S mutans was found immediately after
J Dent Res March 1977
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O KANAMYCIN PATIENTS
* PLACEBO PATIENTS
II nIAa I -a-aaa- IL
6 9 12 15 18 21 24 27 30
TIME AFTER TREATMENT IN MONTHS
FIG 1.-Number of new carious lesions in kanamycin- or placebo-treated
patients seen at recall.
kanamycin treatment, especially in the approx-
imal plaque samples (Table 4). A similar phe-
nomenon was not observed with the placebo
treatment.
In the secondary lesion, an antimicrobial
agent would behave in a manner similar to that
described for the primary lesion. However, be-
cause of the cavitation associated with this le-
sion, it would be diagnosed as carious and de-
brided of carious tissue prior to the placement
of a dental restoration. This should serve to re-
duce the levels of total organisms as well as
S mutans. In the present investigation, the
placement of dental restorations lowered the
salivary and fissure levels of S mutans in all
subjects (Tables 2 and 3). The restorations
wvere less effective in their ability to reduce ap-
proximal levels of S mutans in the kanamycin
groups, which might reflect a selection by the
first kanamycin treatment of S mutans in the
primary lesion.
The cariesfree surfaces and primary lesions
STAGE OF TREATMENT KANAMYCIN PLACEBO LEEND FOR SYMBOLS
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would have different S mutans profiles at the
completion of the restoration and gel treatments
(Fig 2), which would predict different treat-
ment outcomes durinig the recall period. In the
kanamycin groups, the cariesfree surfaces may
be rid of an S mutans infection and stay that
way during the recall period. Another investi-
gation has shown that if disinfcction with
iodine is successful in removing S mutans from
a tooth surface, that surface may remain free of
S mutans for a considlerable period of time fol-
lowing treatment.16 Thus, the cariesfree sur-
faces in the kanamycin group may remain that
way because of the absence of, or low level of a
S mutans infection. In the placebo group, the
cariesfree surfaces would still contain S mu-
ans, and this fact might account for the event-
Lual development of caries on these surfaces
during the recall visits.
The primary lesion would also respond
differently to the kanlamycin or placebo treat-
ment. The kanamycin might kill plaque organ-
isms on the surface, but would leave unaltered
those organisms buried in the primary lesions
found in fissures, and on approximal, and
smooth surfaces. These residual organisms
would dominate in the plaque which reforms
on these surfaces, as described previously and
depicted in Fig. 2. A similar selection for these
organisms in the primary lesions of the placebo-
treated group would not occur. The net result
of this selection might be an accelerated caries
rate in the kanamycin group relative to the
placebo group, if the surviving organisms have
cariogenic potential. This indeed was the case,
as the kanamycin group had seven times the
number of new carious lesions at the nine-
month recall visit than did the placebo group.
This model explains some of the observa-
tioins obtained during this investigation and pro-
vides suggestions for future chemotherapy for
plaque infection. In particular, it shows how
the increased proportions of S mutans immedi-
ately followving kanamycin gel treatment can be
explained and related to subsequent accelerated
caries development in the kanamycin group.
The model does not state that S mutans is the
exclusive microbial determinant of caries. The
long-term caries reduction in the kanamycin
group, however. is strong evidence for a spe-
cific microbial component such as S mutans in
human decay.
The model indicates that antimicrobial
treatment prior to the placement of dental re-
storations or in the presence of primary and
secondary lesionis will be counterproductive, as
such treatment will select for organisms buried
wvithin the lesions. If these organisms have
cariogenic potential, such as S mutans, then an
accelerated caries attack rate might ensue. The
primary lesion in some, if not all cases, will be
a zone of subsurface demineralization. An anti-
microbial agent whicli is capable of penetrat-
ing into this zone might be the agent of choice.
Topical fluerides promote remineralizationl7
and fluoride is found in elevated amounts in
sites of arrested caries.'8 Accordingly, we have
switched to short, intensive fluoride therapy,
i.e., two times a day for one week in an effort to
combat new carious lesions in these rapid caries
patients. Preliminary data, obtained at the six-
to nine-month recall visits, indicate the netu-
tral 1.2% sodium fluoride is causing about a 50
to 60% reduction in caries relative to a placebo
group (Loesche, Pink, and Woolfolk, unpub-
lished data).
The authors thank Rochelle Ronis for technical
assistance.
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